Cargando…

Development of Viral Vectors for Gene Therapy for Chronic Pain

Chronic pain is a major health concern that affects millions of people. There are no adequate long-term therapies for chronic pain sufferers, leading to significant cost for both society and the individual. The most commonly used therapy for chronic pain is the application of opioid analgesics and n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yu, Liu, Xin, Dong, Lanlan, Liu, Zhongchun, He, Xiaohua, Liu, Wanhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200086/ https://www.ncbi.nlm.nih.gov/pubmed/22110937 http://dx.doi.org/10.1155/2011/968218

Ejemplares similares

Current gene therapy using viral vectors for chronic pain
por: Guedon, Jean-Marc G, et al.
Publicado: (2015)

Viral Vector-Based Gene Therapy
por: Li, Xuedan, et al.
Publicado: (2023)

Development of Viral Vectors for Use in Cardiovascular Gene Therapy
por: Williams, Paul D., et al.
Publicado: (2010)

Viral Vectors in Gene Therapy
por: Lundstrom, Kenneth
Publicado: (2018)

Foamy Virus Integrase in Development of Viral Vector for Gene Therapy
por: Kim, Jinsun, et al.
Publicado: (2020)

Coxsackievirus A16 Elicits Incomplete Autophagy Involving the mTOR and ERK Pathways
por: Shi, Yingying, et al.
Publicado: (2015)

Non-viral Vectors in Gene Therapy: Recent Development, Challenges, and Prospects
por: Zu, Hui, et al.
Publicado: (2021)

Novel Viral Vector Systems for Gene Therapy
por: Stone, Daniel
Publicado: (2010)

Engineering targeted viral vectors for gene therapy
por: Waehler, Reinhard, et al.
Publicado: (2007)

Immune Responses to Viral Gene Therapy Vectors
por: Shirley, Jamie L., et al.
Publicado: (2020)

Viral Vector-Based Melanoma Gene Therapy
por: Hromic-Jahjefendic, Altijana, et al.
Publicado: (2020)

Viral vector‐based gene therapies in the clinic
por: Zhao, Zongmin, et al.
Publicado: (2021)

The Development of Functional Non-Viral Vectors for Gene Delivery
por: Patil, Suryaji, et al.
Publicado: (2019)

Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies
por: Caffery, Breanne, et al.
Publicado: (2019)

Advances in Non-Viral DNA Vectors for Gene Therapy
por: Hardee, Cinnamon L., et al.
Publicado: (2017)

Non-viral Vector for Muscle-Mediated Gene Therapy
por: Braun, Serge
Publicado: (2018)

Viral Vectors as Gene Therapy Agents for Treatment of Glioblastoma
por: Mozhei, Oleg, et al.
Publicado: (2020)

Viral vector platforms within the gene therapy landscape
por: Bulcha, Jote T., et al.
Publicado: (2021)

Innate Immune Response to Viral Vectors in Gene Therapy
por: Wang, Yixuan, et al.
Publicado: (2023)

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
por: Mata-Espinosa, Dulce, et al.
Publicado: (2023)

Interaction between CRHR1 and BDNF Genes Increases the Risk of Recurrent Major Depressive Disorder in Chinese Population
por: Xiao, Zheman, et al.
Publicado: (2011)

The long non-coding RNA expression profile of Coxsackievirus A16 infected RD cells identified by RNA-seq
por: Shi, Yingying, et al.
Publicado: (2016)

Development of novel SARS-CoV-2 viral vectors
por: Liu, Huan, et al.
Publicado: (2023)

Cancer Gene Therapy Goes Viral: Viral Vector Platforms Come of Age
por: Bezeljak, Urban
Publicado: (2022)

Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer
por: Norian, Lyse A., et al.
Publicado: (2011)

Prospects for Foamy Viral Vector Anti-HIV Gene Therapy
por: Nalla, Arun K., et al.
Publicado: (2016)

Application of Non-Viral Vectors in Drug Delivery and Gene Therapy
por: Ren, Shuaikai, et al.
Publicado: (2021)

Viral Vectors
por: Holman, David H., et al.
Publicado: (2009)

Viral vectors : gene therapy and neuroscience applications /
Publicado: (1995)

Immune Responses to Gene Editing by Viral and Non-Viral Delivery Vectors Used in Retinal Gene Therapy
por: Ren, Duohao, et al.
Publicado: (2022)

ZNF219, a novel transcriptional repressor, inhibits transcription of the prototype foamy virus by interacting with the viral LTR promoter
por: Yuan, Peipei, et al.
Publicado: (2023)

Emerging non-viral vectors for gene delivery
por: Wang, Chenfei, et al.
Publicado: (2023)

Negative life events and corticotropin-releasing-hormone receptor1 gene in recurrent major depressive disorder
por: Liu, Zhongchun, et al.
Publicado: (2013)

Human Pirh2 is A Novel Inhibitor of Prototype Foamy Virus Replication
por: Dong, Lanlan, et al.
Publicado: (2015)

Prototype foamy virus elicits complete autophagy involving the ER stress-related UPR pathway
por: Yuan, Peipei, et al.
Publicado: (2017)

A new non-viral vector for gene-therapy in rheumatic diseases
por: Vervoordeldonk, MJBM, et al.
Publicado: (2002)

Technique of retinal gene therapy: delivery of viral vector into the subretinal space
por: Xue, K, et al.
Publicado: (2017)

In vivo gene delivery mediated by non-viral vectors for cancer therapy
por: Mohammadinejad, Reza, et al.
Publicado: (2020)

VSeq-Toolkit: Comprehensive Computational Analysis of Viral Vectors in Gene Therapy
por: Afzal, Saira, et al.
Publicado: (2020)

Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy
por: Chis, Adriana Aurelia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9fajmklft9f7dqbpg89vdgd590